Abstract:Background: Some neurodegenerative diseases have an element of neuroinflammation that is triggered by viral nucleic acids, resulting in the generation of type I interferons. In the cGAS-STING pathway, microbial and host-derived DNA bind and activate the DNA sensor cGAS, and the resulting cyclic dinucleotide, 2'3-cGAMP, binds to a critical adaptor protein, stimulator of interferon genes (STING), which leads to activation of downstream pathway components. However, there is limited work demonstrating the activation of the cGAS-STING pathway in human neurodegenerative diseases. Methods: Post-mortem CNS tissue from donors with multiple sclerosis (n = 4), Alzheimer's disease (n = 6), Parkinson's disease (n = 3), amyotrophic lateral sclerosis (n = 3) and non-neurodegenerative controls (n = 11) were screened by immunohistochemistry for STING and relevant protein aggregates (e.g., amyloid-β, α-synuclein, TDP-43). Human brain endothelial cells were cultured and stimulated with the STING agonist palmitic acid (1-400 μM) and assessed for mitochondrial stress (release of mitochondrial DNA into cytosol, increased oxygen consumption), downstream regulator factors, TBK-1/pIRF3 and inflammatory biomarker interferon-β release and changes in ICAM-1 integrin expression. Results: In neurodegenerative brain diseases, elevated STING protein was observed mainly in brain endothelial cells and neurons, compared to non-neurodegenerative control tissues where STING protein staining was weaker. Interestingly, a higher STING presence was associated with toxic protein aggregates (e.g., in neurons). Similarly high STING protein levels were observed within acute demyelinating lesions in multiple sclerosis subjects. To understand non-microbial/metabolic stress activation of the cGAS-STING pathway, brain endothelial cells were treated with palmitic acid. This evoked mitochondrial respiratory stress up to a ~2.5-fold increase in cellular oxygen consumption. Palmitic acid induced a statistically significant increase in cytosolic DNA leakage from endothelial cell mitochondria (Mander's coefficient; p < 0.05) and a significant increase in TBK-1, phosphorylated transcription factor IFN regulatory factor 3, cGAS and cell surface ICAM. In addition, a dose response in the secretion of interferon-β was observed, but it failed to reach statistical significance. Conclusions: The histological evidence shows that the common cGAS-STING pathway appears to be activated in endothelial and neural cells in all four neurodegenerative diseases examined. Together with the in vitro data, this suggests that the STING pathway might be activated via perturbation of mitochondrial stress and DNA leakage, resulting in downstream neuroinflammation; hence, this pathway may be a target for future STING therapeutics.

Novel pathomechanistic insights into lysosomal storage disorders: how neuron-intrinsic cGAS-STING signaling drives disease progression

Lysosomal Control of the Cgas-Sting Signaling.

Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders

Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders

The cytosolic DNA‐sensing cGAS–STING pathway in neurodegenerative diseases

cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases

Cellular functions of cGAS-STING signaling

Neuronal STING activation in amyotrophic lateral sclerosis and frontotemporal dementia

Novel Insights into Parkin-Mediated Mitochondrial Dysfunction and "Mito-Inflammation" in α-Synuclein Toxicity. The Role of the cGAS-STING Signalling Pathway

Exploring the nexus of cGAS STING pathway in neurodegenerative terrain: A therapeutic odyssey

cGAS- Stimulator of Interferon Genes Signaling in Central Nervous System Disorders

Advances in cGAS-STING Signaling Pathway and Diseases

The cGAS–STING pathway as a therapeutic target in inflammatory diseases

The role of STING signaling in central nervous system infection and neuroinflammatory disease

deficiency triggers autoinflammation via cGAS-STING activation

STING-Triggered CNS Inflammation in Human Neurodegenerative Diseases

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

Nanoparticle targeting cGAS-STING signaling in disease therapy

Role of cGAS-Sting Signaling in Alzheimer's Disease

RIG-I mediated neuron-specific IFN type 1 signaling in FUS-ALS induces neurodegeneration and offers new biomarker-driven individualized treatment options for (FUS-)ALS

The Role of cGAS-STING Signalling in Metabolic Diseases: from Signalling Networks to Targeted Intervention